From: HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP
 | Kagoshima |  | Kumamoto |  | |||||
---|---|---|---|---|---|---|---|---|---|
 | HAM/TSP |  | AC |  | AC |  | |||
Number of patients in: | Strong HBZ | Weak HBZ | Total | Strong HBZ | Weak HBZ | Total | Strong HBZ | Weak HBZ | Total |
Whole cohort | 81 | 148 | 229 | 92 | 110 | 202 | 34 | 64 | 98 |
All LM-PCR | 42 | 62 | 104 | 41 | 59 | 100 | 34 | 64 | 98 |
LM-PCR QC pass | 39 | 56 | 95 | 30 | 38 | 68 | 24 | 51 | 75 |
Number of UIS* with abundance: | |||||||||
<1 per 10,000 PBMC | 7954 | 12341 | 20295 | 1451 | 5485 | 6936 | 4572 | 9744 | 14316 |
1-10 per 10,000 PBMC | 10051 | 12429 | 22480 | 2178 | 2515 | 4693 | 1034 | 1853 | 2887 |
>10 per 10,000 PBMC | 219 | 364 | 583 | 102 | 67 | 169 | 42 | 40 | 82 |
All | Â | Â | 43358 | Â | Â | 11798 | Â | Â | 17285 |